Back to search

Article

Progress of bacteriophage as therapeutic agent against Helicobacter pylori, especially in India

2025-04-25

Abstract excerpt

Helicobacter pylori (H. pylori), the major causative agent for gastrointestinal disorders, including peptic ulcer, gastritis, and gastric cancer, infects approximately 50% global and 75–80% of Indian population. The standard triple therapy is increasingly compromised by rising antimicrobial resistance (AMR) and development of Multidrug resistant strains. The crisis with the AMR even amplifies in India, it being th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dbe13b16-9446-55af-b3a5-fe6a2e16a119
DOI
10.1007/s42452-025-06971-w
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Progress of bacteriophage as therapeutic agent against Helicobacter pylori, especially in IndiaDOI 10.1007/s42452-025-06971-w
Select a neighboring publication to make it the new centre.